Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
P/E ratio for Microbot Medical Inc. (MBOT)
P/E ratio as of 2023: -1.56
According to Microbot Medical Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.56. At the end of 2022 the company had a P/E ratio of 0.21.
P/E ratio history for Microbot Medical Inc. from 1991 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -1.56 |
| 2022 | 0.21 |
| 2021 | -4.73 |
| 2020 | -5.30 |
| 2019 | -5.90 |
| 2018 | -0.69 |
| 2017 | -4.39 |
| 2016 | -9.02 |
| 2015 | -1.37 |
| 2014 | -1.77 |
| 2013 | -2.02 |
| 2012 | -1.65 |
| 2011 | -0.55 |
| 2010 | -5.28 |
| 2009 | -4.94 |
| 2008 | -3.87 |
| 2007 | -4.78 |
| 2006 | -10.43 |
| 2005 | -18.70 |
| 2004 | -13.69 |
| 2003 | -5.17 |
| 2002 | -2.64 |
| 2001 | -22.51 |
| 2000 | -4.42 |
| 1999 | -1.75 |
| 1998 | -2.13 |
| 1997 | -3.71 |
| 1996 | -10.17 |
| 1995 | -27.26 |
| 1994 | -3.00 |
| 1993 | -10.26 |
| 1992 | -6.06 |
| 1991 | -9.60 |